
è¶ å å·¥é£åãé£ã¹ããã³ã«ãè³ã«"ãŽã"ãæºãŸãã¹ããŒããäžãã£ãŠããã
è¶ å å·¥é£åãäœã«æªãããšèªäœã¯ãããã»ãšãã©ã®äººãç¥ã£ãŠãããšæãã倪ããç³å°¿ç ã«ãªããå¿èã«æªãããã®ãããã¯ããããèšãããŠããã
ã§ããè³ã®è©±ã¯ãŸã ããŸãç¥ãããŠããªãã
2024ã2025幎ã«åºã倧åç ç©¶ãèŠããšãè¶ å å·¥é£åã1æ¥1é£å¢ããã ãã§ã¢ã«ããã€ããŒã®ãªã¹ã¯ã13%äžãã£ãŠãããããŒãã³ãœã³ç ã®åæå åã2.5åã«ãªããšããããŒã¿ãããã倪ãâã¡ã¿ãâç æ°ãã ããããªããäœéãå€ãããªããŠããè³ã®äžã§äœããèµ·ããŠããã
1000äžäººã®ããŒã¿ã瀺ããã32ã®ç æ°ã
2024幎ãBMJïŒBritish Medical JournalïŒã«æ²èŒãããã¢ã³ãã¬ã©ã¬ãã¥ãŒããããLane MMãã®ç ç©¶ã§ã14æ¬ã®ã¡ã¿åæã45ã®çµ±åè§£æããŸãšãããã®ã察象ã¯ã®ã¹çŽ988äžäººã
çµæã¯ãè¶ å å·¥é£åã®æåéãå€ã人ã»ã©ã32ã®å¥åº·ææšã§æªåãèŠãããŠããããããå¿çŸæ£ã2åç³å°¿ç ããã€ãè¥æºãæ©ææ»äº¡ããšããã³ã¹ã®ç¢ºå®æ§ããconvincingïŒç¢ºä¿¡çïŒããšè©äŸ¡ããããã®ããã£ãã
ãããŸã§ã¯ããŸããããã ãããªããšããæèŠã®äººãå€ããšæãã
åé¡ã¯ããããã ã
1æ¥1é£å¢ãããã³ã«ãã¢ã«ããã€ããŒã®ãªã¹ã¯ã13%äžããïŒè¶ å å·¥é£åãšã¢ã«ããã€ããŒïŒ
2025幎ããã©ãã³ã¬ã å¿èç ç©¶ã®ããŒã¿ã䜿ã£ãååãã³ããŒãç ç©¶ãçºè¡šãããïŒWeinstein GããJ Prev Alzheimer's Dis, 2025ïŒã60æ³ä»¥äžã§èªç¥çã®ãªã1,375人ããå¹³å12.7幎远跡ããŠããã
68æ³æªæºã®åå è ã«ãããŠãè¶ å å·¥é£åã1æ¥1é£ïŒ1ãµãŒãã³ã°ïŒå¢ããããšã«ãã¢ã«ããã€ããŒç ã®ãªã¹ã¯ã13%äžãã£ãŠããïŒHR=1.13, 95%CI:1.03-1.25ïŒã

ããã«ã1æ¥10é£ä»¥äžã®è¶ å å·¥é£åãé£ã¹ãŠãã人ã¯ã10飿ªæºã®äººãšæ¯ã¹ãŠã¢ã«ããã€ããŒã®ãªã¹ã¯ã2.7åã ã£ãïŒHR=2.71, 95%CI:1.18-6.24ïŒãå¹Žéœ¢ãæ§å¥ãæè²æŽãç·ãšãã«ã®ãŒæåéã代è¬å åãé£äºã®è³ªã§èª¿æŽããåŸã®æ°åã ã
ããã§ã10é£ããšèããšãããå€ãå°è±¡ãåãããããããªããã§ãæ°ããŠã¿ããšãæã®èåãã³ã«çŒ¶ã³ãŒããŒãæŒã®ã«ãã麺ã«ã¹ããã¯èåãå€ã®å·åãã¶ã«å ç³é£²æãããã€ã®ãã§ã³ããŒã«ããããããã§8é£ãæå€ãšé ããªãã
ããšäžã€å€§äºãªããšããã®é¢é£ãèŠãããã®ã¯68æ³æªæºã®çŸ€ã§ã68æ³ä»¥äžã§ã¯ææå·®ããªãã£ããã€ãŸããäžå¹Žæã®é£ç¿æ £ãè³ã®å°æ¥ãå·Šå³ããå¯èœæ§ãããã60ä»£ã§æ ãŠãŠé£äºãå€ããããã40代50代ã®ãã¡ã«æãæã€æ¹ãããã
ããŒãã³ãœã³ç ã®åæå åã2.5åã«ïŒè¶ å å·¥é£åãšããŒãã³ãœã³ç ïŒ
ã¢ã«ããã€ããŒã ãã§ã¯ãªãã
2025幎5æã«Neurologyèªã«æ²èŒãããç ç©¶ïŒWang Pãã埩æŠå€§åŠã»ããŒããŒãå ¬è¡è¡ç倧åŠé¢ïŒã§ã¯ã42,800人以äžã®å»çå°éè·ã1980幎代äžé ãã远跡ããè¶ å å·¥é£åã®æåéãšããŒãã³ãœã³ç ã®åé§çç¶ã®é¢é£ã調ã¹ãŠããã
ããŒãã³ãœã³ç ã¯ãæã®éããæ©è¡é害ãåºãäœå¹Žããå Žåã«ãã£ãŠã¯äœå幎ãåãããåé§çç¶ãšåŒã°ãããµã€ã³ãåºãŠãããã¬ã ç¡ç è¡åé害ãå èŠã®äœäžãæãã€çç¶ãäœã®çã¿ãè²èŠç°åžžãæ¥äžã®é床ãªç æ°ã
çµæã1æ¥11é£ä»¥äžã®è¶ å å·¥é£åãé£ã¹ãŠãã人ã¯ã3飿ªæºã®äººãšæ¯ã¹ãŠããããã®åé§çç¶ã3ã€ä»¥äžæã£ãŠãããªããºã2.5åã ã£ãã
䟿ç§ãé€ãã»ãŒãã¹ãŠã®åå¥çç¶ã§ãæåéãå€ãã»ã©ãªã¹ã¯ãäžãããšããçšéåå¿é¢ä¿ãèªããããŠããã
ã¡ãªã¿ã«è¶ å å·¥é£åãšå¿èã®è©±ã¯ãå¥ã®èšäºã§è©³ãããŸãšããŠããããã«ããªãŒç®¡çããŠããã倧äžå€«ããéçšããªãçç±ãããããšæãã
倪ããããã¡ããããªãã£ãïŒè ž-è³ççã«ãŒãïŒ
ããããã¯èªåã®è§£éãå ¥ãã
è¶ å å·¥é£åã®ãªã¹ã¯ã¯ãã«ããªãŒãé«ãâ倪ãâçæŽ»ç¿æ £ç âè³ã«ãæªåœ±é¿ããšããäžæ¬éã ããããªãããã©ãã³ã¬ã ã®ç ç©¶ã§ã¯ãè¥æºãç³å°¿ç ã®åœ±é¿ãå·®ãåŒããŠããã¢ã«ããã€ããŒç ã®ãªã¹ã¯ã¯æ®ã£ãŠããã倪ã£ãŠããããè³ã«æªãããããªããŠãè¶ å å·¥é£åãã®ãã®ãè³ã«äœãããŠããå¯èœæ§ãããã
ãã ãæ£çŽã«èšããšããèªç¥çå šäœãã§ãŸãšãããšçµ±èšçã«ã®ãªã®ãªã®ã©ã€ã³ã§ãè¥æºã«ãŒããšå®å šã«åãé¢ããããã§ã¯ãªããããã§ãã¢ã«ããã€ããŒç ã«çµãã°ã©ã®åæã§ãé¢é£ãæ¶ããªãã£ããããã¯æ³šç®ããŠããã
æåãªã®ããè ž-è³ã«ãŒããã

è¶ å å·¥é£åã«å«ãŸããä¹³åå€ã人工ç峿ãä¿åæãè žå 现èã®ãã©ã³ã¹ã厩ããè žå ç°å¢ãä¹±ãããšãè žç®¡ã®ããªã¢æ©èœãäœäžããŠççæ§ã®ç©è³ªãè¡äžã«æŒãåºãããã®ççã·ã°ãã«ãè¡æ¶²è³é¢éãè¶ããŠãè³ã®æ ¢æ§çãªççãåŒãèµ·ãããè³ã«ãšã£ãŠã¯ãæ¯é£ã¡ãã£ãšãã€ç ãåžãç¶ããŠãããããªãã®ã ã
ãªãã人工ç峿ã«ã€ããŠã¯ä»¥äžã®èšäºã§æ·±æãããã
åç©å®éšã§ã¯ãé«åºŠå å·¥é£ãäžããããŠã¹ã§è žå 现èå¢ã®å€åãšç¥çµççããŒã«ãŒã®äžæãåçŸãããŠãããããã§ã®å æé¢ä¿ã¯ãŸã 確å®ããŠããªãããã¡ã«ããºã ã®çã¯éã£ãŠããã
ã¡ãªã¿ã«ãã¡ããã©å é±å€æ¥ã§50ä»£ã®æ£è ããã«ãå çãã¡ã¿ããããªãããé£äºã¯å€§äžå€«ã§ãããããšèããããBMI 22ã§è¡æ¶²ããŒã¿ãåé¡ãªããã§ãæŒã¯æ¯æ¥ã³ã³ããã®ãµã³ãã€ãããšãšããžãŒããªã³ã¯ã ãšèšãã®ã§ãã¡ãã£ãšåŸ ã£ãŠãããšãäœéãæ£åžžã§ãè³ã®äžã§äœãèµ·ããŠãããã¯å¥ã®è©±ã ã
ãã®ç ç©¶ã®éçãæ£çŽã«æžããŠãã
ãããŸã§èªãã§ãè¶ å å·¥é£åãããªããããšæã£ã人ããããããããªããã©ãããã€ãçæããŠã»ããç¹ãããã
玹ä»ããç ç©¶ã¯ãã¹ãŠèгå¯ç ç©¶ã ããè¶ å å·¥é£åãé£ã¹ãããèªç¥çã«ãªã£ãããšãŸã§ã¯èšããªããè¶ å å·¥é£åãããããé£ã¹ã人ã¯ãéåéãå°ãªãã£ããã瀟äŒçå€ç«ããã£ãããä»ã®çæŽ»ç¿æ £ã«ãåé¡ãæ±ããŠããå¯èœæ§ããããç ç©¶è ã¯ãããã亀絡å åãçµ±èšçã«èª¿æŽããŠããããå®å šã«æé€ã§ããããã§ã¯ãªãã
ãã©ãã³ã¬ã ã®ç ç©¶ã¯1,375人ã§ãèŠæš¡ãšããŠã¯ãããŸã§å€§ãããªãã察象ããã¹ãã³è¿éã®ã³ãã¥ããã£ã§ã人皮ãæåçèæ¯ã®å€æ§æ§ã«ã¯éçããããããŒãã³ãœã³ã®ç ç©¶ãèªå·±ç³åã®é£äºããŒã¿ã§ãèšæ¶ã«é Œãéšåãããã
ãã ãè€æ°ã®ç¬ç«ããç ç©¶ã§ãç°ãªãéå£ã察象ã«ãäžè²«ããŠè¶ å å·¥é£åãšèªç¥æ©èœã®æªåã®é¢é£ãåºãŠãããBMJã®ã¢ã³ãã¬ã©ã¬ãã¥ãŒã§ãã¡ã³ã¿ã«ãã«ã¹ãžã®åœ±é¿ã¯ãsuggestiveïŒç€ºåçïŒã以äžã®ãšããã³ã¹ã¬ãã«ãšè©äŸ¡ããããåç©å®éšã§ã¡ã«ããºã ãåçŸãããŠããç¹ãå«ãããšããå¶ç¶ã®é¢é£ããšçä»ããã«ã¯èšŒæ ãæããããŠããã
ããããäœãããã°ããã
å®å šã«è¶ å å·¥é£åãæé€ããå¿ èŠã¯ãªãããçŸå®çã«ãç¡çã ãå³åã逿²¹ã猶詰ãšãã£ã調çã«äœ¿ãå å·¥é£åïŒNOVAåé¡ã®Group 1ã3ïŒã¯è¶ å å·¥é£åã«ã¯å«ãŸããªããããã§èšã£ãŠããè¶ å å·¥é£åã¯NOVAåé¡ã®Group 4ãã€ãŸãèåãã³ãã«ãã麺ãå·åãã¶ãå ç³é£²æãã¹ããã¯èåãããã±ãŒãžå ¥ãã®çãã·ãªã¢ã«ãªã©ãæãã
ããããšã¯äžã€ã ãã1æ¥ã®ãã¡1é£ã§ããããããå å·¥ãããŠããªããã®ãã«çœ®ãæããã
èªåãããããããã®ã¯æŒé£ã ãã³ã³ããã®ãµã³ãã€ãããã«ãã麺ãããã«ããïŒèªåã§æ¡ã£ããã®ïŒïŒãã§åµïŒã¿ãæ±ã«å€ããã ãã§ããè¶ å å·¥é£åã®æåéã¯å€§ããæžãããããªãå šéšå€ããããšãããšç¶ããªãã
ããšã¯é£²ã¿ç©ãå ç³é£²æããšããžãŒããªã³ã¯ãæ°Žããè¶ã«å€ãããããã ãã§1æ¥2ã3ãµãŒãã³ã°ã¯æžãããã
çµå±ã®ãšãããèªç¥çã®äºé²ã¯ç¹å¥ãªãµããªãæ€æ»ã§ã¯ãªããŠãæ¯æ¥ã®é£åã«ããã
ãŸãšã
BMJã¢ã³ãã¬ã©ã¬ãã¥ãŒïŒçŽ988äžäººïŒïŒè¶ å å·¥é£åã®å€æåã¯32ã®å¥åº·ææšãšé¢é£
ãã©ãã³ã¬ã ïŒ68æ³æªæºã§1é£/æ¥å¢å ããšã«ã¢ã«ããã€ããŒãªã¹ã¯+13%ã10é£/æ¥ä»¥äžã§2.7å
Neurology 2025ïŒ1æ¥11é£ä»¥äžã§ããŒãã³ãœã³åé§çç¶3ã€ä»¥äžã®ãªããº2.5å
è¥æºã»ç³å°¿ç ã調æŽããŠãæ®ããªã¹ã¯ãè ž-è³ã®æ ¢æ§ççã«ãŒããæå仮説
æé€ã¯ãããªãã1æ¥1é£ããå å·¥ãããŠããªããã®ãã«çœ®ãæãããå ç³é£²æãæ°Ž/ãè¶ã«
ãããŸã§èªãã§ãã ãã£ãŠããããšãããããŸããã
ãã¹ãããæŒããŠãããããšããã¡ããã¡ãå±ã¿ã«ãªããŸãã
ãã©ããŒããŠãããããšæ°ããèšäºãå±ããŸãã
ãã£ãšæ·±ãç¥ãããæ¹ãžïŒé¢é£èšäºïŒ
⌠ãå å·¥ãããŠããªããã®ãããåæé£ã§ã
æ¬èšäºã®ã1æ¥1é£ã眮ãæããããå
·äœçã«è§£èª¬ããŠããŸããã¿ãæ±ïŒçŽè±ãã¯ãïŒãããã§èãšãšãµãåæã«ãšããåæé£ã®ç§åŠçæ ¹æ ãæžããŸããã
⌠è¶
å å·¥é£åããäœã«æ¿ãããããŸã§æ±ºãããæ¹ãžïŒã¡ã³ããŒéå®ïŒ
ãã€ã³ã°ã®ããšã«éæ±ã飲ãã§ããè³ã¯ãã£ã©ã«ããŠãããªã
é·æã®èªç¥çãªã¹ã¯ã§ã¯ãªããååŸã®æ³šæåãŸã§å«ããŠãæ¯æ¥ã®è¶
å å·¥é£åãã©ãããæžãããäœã«æ¿ããããæžããŠããŸãã
⌠è
žâè³ã«ãŒãã2026幎Natureã§å
·äœåãã
æ¬èšäºã®ãè
ž-è³ççã«ãŒãããã¹ã¿ã³ãã©ãŒãã®ããŒã ãå
·äœçãªèçš®ã»å容äœã»ç¥çµçµè·¯ãŸã§è¿œããããææ°è«æã®è§£èª¬ã§ãã
ã¡ã³ããŒã·ãããDr.ãããã©ããã®ãç¥ãã
ã¡ã³ããŒã·ãããDr.ãããã©ãããéå¶ããŠããŸããXã»ç¡ænoteã§ã¯åºããªããããäžæ®µèžã¿èŸŒãã è©±ãæžããŠããŸãã
çµå¶è ã®äž»æ²»å»ãšããŠã倿¥ã§å®éã«è©±ããŠããå 容
è«æãèªã¿ãªããèªåã®äœã§è©Šãããå¹ããã»å¹ããªãã£ãèšé²
æ€æ»æ°å€ã®èªã¿æ¹ããµããªã»è¬ã®éžã³æ¹
ã¡ã³ããŒéå®ã®æ²ç€ºæ¿Q&A
æé¡1000åã§å šèšäºèªã¿æŸé¡ã§ããåããªãã£ããããè§£çŽã§ããŸããæ°ã«ãªã£ãæ¹ã¯ãèŠããŠã¿ãŠãã ããã
â»ãã®èšäºã®å 容ã¯äžè¬çãªå¥åº·æ å ±ã§ãããåå¥ã®èšºæã»æ²»çãç®çãšãããã®ã§ã¯ãããŸãããå ·äœçãªå¥åº·äžã®åé¡ãããå Žåã¯ã䞻治å»ã«ãçžè«ãã ããã
åèæç®
Lane MM et al. Ultra-processed food exposure and adverse health outcomes: umbrella review of epidemiological meta-analyses. BMJ. 2024;384:e077310.
Weinstein G et al. Ultra-processed food consumption and risk of dementia and Alzheimer's disease: The Framingham Heart Study. J Prev Alzheimer's Dis. 2025.
Wang P et al. Long-Term Consumption of Ultraprocessed Foods and Prodromal Features of Parkinson Disease. Neurology. 2025;104(11):e213562.
Li H et al. Association of Ultraprocessed Food Consumption With Risk of Dementia: A Prospective Cohort Study. Neurology. 2022;99(10):e1056-e1066.